ArticleThe Laryngoscope2025
HPV6-Induced Gene Expression Signature in Recurrent Respiratory Papillomatosis.
Article in The Laryngoscope, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- HPV6-Induced Gene Expression Signature in Recurrent Respiratory Papillomatosis.The Laryngoscope · 2025Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectivesRecurrent respiratory papillomatosis (RRP) is caused by human papillomavirus (HPV) types 6 and 11. However, the cellular and molecular mechanisms underlying its pathogenesis remain to be elucidated. Recently, the conditional reprogramming (CR) method, which reprograms epithelial cells to an undifferentiated stem cell state, has been shown to be effective for studying RRP. Here, we investigated the relationship between viral and host gene expression in CR cells and explored the molecular pathogenesis of RRP.
methodsWe evaluated the passage capacity and growth rate of CR cells from fresh RRP tissues and adjacent normal tissues from patients with RRP. Furthermore, we performed RNA-seq analysis of CR cells across multiple passages to characterize the gene expression profiles associated with RRP.
resultsRRP-derived CR cells exhibited greater passage capacity and proliferation rates than adjacent normal tissue-derived CR cells. HPV6 gene was expressed in all RRP-derived CR cells and its expression decreased with each passage. We identified three categories of genes correlated with HPV6: inflammatory genes (e.g., CTSS, CFB), oncogenic genes (e.g., CEACAM5, CEACAM6), and glycosylation-related genes (e.g., ST6GALNAC1, FUT2).
conclusionHPV6-induced gene expression signature in infected epithelial cells may play a role in RRP pathogenesis. Further molecular investigations are necessary to determine whether controlling these genes and related factors can control the progression of RRP. LEVEL OF EVIDENCE: N/A.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.